The increased risk of hypercoagulability induced by gonadotropins, treatments with human chorionic gonadotropin (hCG), and gonadotropin-releasing hormone (GnRH), commonly used medications in infertility treatments (Gerotziafas et al. 2017). Here, GNRH1 is linked to thrombophilia.